Stocksigma LogoStocksigma Logo

Piramal Pharma Receives US FDA Form-483 with Seven Observations for Morpeth Facility

The US FDA conducted a GMP inspection at Piramal Pharma鈥檚 Morpeth, UK facility from 3rd Sep'26 to 11th Sep'26, concluding with the issuance of Form-483

Piramal Pharma Receives US FDA Form-483 with Seven Observations for Morpeth Facility

Piramal Pharma Ltd 路 Others (Uncategorized) 路 15 Sept 2026, 1:20 am

Piramal Pharma Receives US FDA Form-483 with Seven Observations for Morpeth Facility The US FDA conducted a GMP inspection at Piramal Pharma鈥檚 Morpeth, UK facility from 3rd Sep'26 to 11th Sep'26, concluding with the issuance of Form-483 containing 7 observations. The observations relate to enhancements in operational practices, procedures, and documentation. Piramal Pharma stated it is actively addressing these points and preparing a detailed response for submission to the US FDA within the stipulated timeline, aiming to resolve all matters in close coordination with the regulator.

Original exchange filing (PDF)

More announcements from Piramal Pharma Ltd

All Piramal Pharma Ltd announcements